SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibodies Share News (FAB)

Share Price Information for Fusion Antibodies (FAB)

Share Price is delayed by 15 minutes
Get Live Data
12.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.00 (8.696%)
Market Cap: £15.02m
FAB Live PriceLast checked at - London Stock Exchange

Intraday Fusion Antibodies Share Chart

Fusion Antibodies News

DIRECTOR DEALINGS SUMMARY: TalkTalk Telecom Boss Buys GBP200,000 Worth
3 Feb 2020

DIRECTOR DEALINGS SUMMARY: TalkTalk Telecom Boss Buys GBP200,000 Worth

DIRECTOR DEALINGS SUMMARY: TalkTalk Telecom Boss Buys GBP200,000 Worth

Fusion Antibodies Expects Annual Revenue Rise Ahead Of Expectations
29 Jan 2020

Fusion Antibodies Expects Annual Revenue Rise Ahead Of Expectations

Fusion Antibodies Expects Annual Revenue Rise Ahead Of Expectations

Fusion Antibodies sees 'favourable trends' continue in H2
29 Jan 2020

Fusion Antibodies sees 'favourable trends' continue in H2

(Sharecast News) - Pre-clinical therapeutic drug and diagnostics firm Fusion Antibodies said on Wednesday that trading in the third quarter of the fin...

DIRECTOR DEALINGS: Fusion Antibodies Non-Executive Mawson Buys Shares
10 Jan 2020

DIRECTOR DEALINGS: Fusion Antibodies Non-Executive Mawson Buys Shares

DIRECTOR DEALINGS: Fusion Antibodies Non-Executive Mawson Buys Shares

DIRECTOR DEALINGS: Fusion Antibodies Non-Exec Mawson Buys Shares
3 Dec 2019

DIRECTOR DEALINGS: Fusion Antibodies Non-Exec Mawson Buys Shares

DIRECTOR DEALINGS: Fusion Antibodies Non-Exec Mawson Buys Shares

Fusion Antibodies cuts losses after revenue leaps
2 Dec 2019

Fusion Antibodies cuts losses after revenue leaps

(Sharecast News) - Fusion Antibodies on Monday reported a narrowed loss after revenue more than doubled following the launch of its RAMP service.

Fusion Antibodies Revenue Takes Off But Order Visibility Cloudy
2 Dec 2019

Fusion Antibodies Revenue Takes Off But Order Visibility Cloudy

Fusion Antibodies Revenue Takes Off But Order Visibility Cloudy

Fusion Antibodies pleased with progress in first half
22 Oct 2019

Fusion Antibodies pleased with progress in first half

(Sharecast News) - Preclinical antibody discovery company Fusion Antibodies updated the market on the six months ended 30 September on Tuesday, report...